Sequent Scientific Ltd.
| BSE: 512529 | Sector: Health care |
| NSE: SEQUENT | ISIN Code: INE807F01027 |
| BSE 00:00 | 14 Jun | 266.80 |
-5.20 (-1.91%) |
OPEN
272.00 |
HIGH
273.25 |
LOW
263.60 |
| NSE 00:00 | 14 Jun | 266.60 |
-5.30 (-1.95%) |
OPEN
272.90 |
HIGH
273.95 |
LOW
263.05 |
| OPEN | 272.00 |
| PREVIOUS CLOSE | 272.00 |
| VOLUME | 116931 |
| 52-Week high | 311.95 |
| 52-Week low | 84.50 |
| P/E | 177.87 |
| Mkt Cap.(Rs cr) | 6,626 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Sequent Scientific Ltd.
Sequent Scientific Ltd
Visistha Traders & Finance Ltd has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12 2003....> More
Sequent Scientific Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
6,626 | |
| EPS - TTM | () |
[*S] | 1.50 |
| P/E Ratio | (X) | [*S] | 177.87 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 10.00 | |
| Latest Dividend Date | 21 Aug 2019 | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 39.94 |
| P/B Ratio | () |
[*S] | 6.68 |
Announcement
-
Non-Applicability Of SEBI Circular-SEBI/HO/DDHS/ CIR/P/2018/144 Dated November 26 2018 With Respect
-
Sequent Scientific Limited - Disclosure under SEBI Takeover Regulations
-
Submission Of Certificate From A Practicing Company Secretary Under Regulation 40(9) Of Securities A
-
Submission Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulatio
-
Statement Of Investor Complaints For The Quarter Ended March 2021
Sequent Scientific Ltd - Financial Results
Particulars ( cr) |
Dec 2020 | Dec 2019 | % Chg |
| Net Sales | 358.21 | 316.42 | 13.21 |
| Other Income | 2.81 | 0.98 | 186.73 |
| Total Income | 361.02 | 317.4 | 13.74 |
| Total Expenses | 291.91 | 266.44 | 9.56 |
| Operating Profit | 69.12 | 50.97 | 35.61 |
| Net Profit | 39.69 | 24.06 | 64.96 |
| Equity Capital | 49.67 | 49.67 | - |
Sequent Scientific Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Strides Pharma | 817.85 | -0.90 | 7335.30 |
| Wockhardt | 647.00 | -1.80 | 7167.47 |
| Aarti Drugs | 726.00 | -0.93 | 6722.76 |
| Sequent Scien. | 266.80 | -1.91 | 6625.98 |
| FDC | 381.40 | 13.18 | 6438.03 |
| Solara Active | 1671.60 | -2.78 | 6006.06 |
| Hikal | 457.65 | -2.56 | 5642.82 |
Sequent Scientific Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherSequent Scientific Ltd - Research Reports
| Date | Broker | Action | Price | Report |
| 13/05/2020 | Nirmal Bang | Buy | 80 |  Details |
Sequent Scientific Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -3.58% | -3.84% | 0.43% | 0.38% |
| 1 Month | 3.95% | 3.92% | 7.84% | 7.73% |
| 3 Month | 13.87% | 13.98% | 3.46% | 5.20% |
| 6 Month | 59.24% | 59.12% | 13.62% | 16.62% |
| 1 Year | 212.78% | 212.91% | 55.57% | 58.55% |
| 3 Year | 347.28% | 343.23% | 47.62% | 46.30% |
Sequent Scientific Ltd - STOCK STRENGTH
| Today's Low/High | 263.60 |
|
273.25 |
| Week Low/High | 261.00 |
|
284.00 |
| Month Low/High | 253.55 |
|
285.00 |
| YEAR Low/High | 84.50 |
|
312.00 |
| All TIME Low/High | 0.37 |
|
312.00 |
Quick Links for Sequent Scientific:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
